Transgenic Mouse Strains as Platforms for the Successful Discovery and Development of Human Therapeutic Monoclonal Antibodies

Publisher： Bentham Science Publishers

E-ISSN： 1875-6220|11|1|74-84

ISSN： 1570-1638

Source： Current Drug Discovery Technologies, Vol.11, Iss.1, 2014-03, pp. : 74-84

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Population Pharmacokinetics of Therapeutic Monoclonal Antibodies

By Dirks Nathanael L.   Meibohm Bernd  

Clinical Pharmacokinetics, Vol. 49, Iss. 10, 2010-10 ,pp. : 633-659

Adis International

Access to resources Recommend Favorite

Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies

By Keizer Ron J.   Huitema Alwin D.R.   Schellens Jan H.M.   Beijnen Jos H.  

Clinical Pharmacokinetics, Vol. 49, Iss. 8, 2010-08 ,pp. : 493-507

Adis International

Access to resources Recommend Favorite

Pharmacogenetics and pharmacogenomics of therapeutic monoclonal antibodies

By Yan Li   Davis Hugh M  

Pharmacogenomics, Vol. 7, Iss. 7, 2006-10 ,pp. : 961-964

Future Medicine

Access to resources Recommend Favorite

Development of a PBPK Model for Monoclonal Antibodies and Simulation of Human and Mice PBPK of a Radiolabelled Monoclonal Antibody

By  

Current Pharmaceutical Design, Vol. 15, Iss. 9, 2009-03 ,pp. : 988-1007

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitory monoclonal antibodies to human cytochrome P450 enzymes: a new avenue for drug discovery

By Gelboin H.V.   Krausz K.W.   Gonzalez F.J.   Yang T.J.  

Trends in Pharmacological Sciences, Vol. 20, Iss. 11, 1999-11 ,pp. : 432-438

Elsevier

Access to resources Recommend Favorite